BEPC Stock Brookfield Renewable Corporation
BUY US · NYSEDiversified renewable infrastructure combines contracted growth with potential valuation recovery.
Future value: $37.57 (+28.14%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Renewable infrastructure exposure remains supported by Moderate Buy sentiment.
- ▾Below 50-day MA (-3.42%)
- ▸Volume 1.53× average — accumulation
- ▾Near 52-week low (9.9% of range)
- ▸~28% upside to price target
Is BEPC a buy right now?
Trend: BEPC is trading below the 50-day average (-3.43%), RSI 46 — neutral momentum, with a 3-month return of -9.90%.
Valuation & quality: Brookfield Renewable Corporation trades on forward P/E -61.7, PEG 2.30; fundamentals show net margin -102.3%, return on equity -45.5%, revenue growth 13.0% year on year.
Analyst consensus: 7 analysts have a mean 12-month price target of $37.57 (+28.1% vs the last close; range $32.00 – $43.00), consensus rating “hold”.
Income: trailing dividend yield 5.41%.
Our screen: BUY (score 3) — Diversified renewable infrastructure combines contracted growth with potential valuation recovery.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -6.80% | -9.00% | +10.30% | -7.20% | -10.20% | -3.60% | -12.20% | +3.90% |
Fundamentals
Analyst price target
Technical signals
About Brookfield Renewable Corporation
Brookfield Renewable Corporation owns and operates a portfolio of renewable power and sustainable solution assets. The company's portfolio consists of hydroelectric, wind, utility-scale solar, distributed generation, pumped storage, carbon capture and storage, cogeneration, biomass, and eFuels.
Sector: Utilities · Industry: Utilities - Renewable · United States · 2,411 employees · Website
Related Clean Energy picks
Browse: all US stocks · Clean Energy picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.